ZA887950B - Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions - Google Patents

Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions

Info

Publication number
ZA887950B
ZA887950B ZA887950A ZA887950A ZA887950B ZA 887950 B ZA887950 B ZA 887950B ZA 887950 A ZA887950 A ZA 887950A ZA 887950 A ZA887950 A ZA 887950A ZA 887950 B ZA887950 B ZA 887950B
Authority
ZA
South Africa
Prior art keywords
mutant proteins
substitution
human
preparation
pharmaceutical compositions
Prior art date
Application number
ZA887950A
Inventor
Pannekoek Hans
Hans Pannekoek
Original Assignee
Stichting Centraal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL8701021A external-priority patent/NL8701021A/en
Application filed by Stichting Centraal Lab filed Critical Stichting Centraal Lab
Priority to ZA887950A priority Critical patent/ZA887950B/en
Publication of ZA887950B publication Critical patent/ZA887950B/en

Links

ZA887950A 1987-04-29 1988-10-24 Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions ZA887950B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA887950A ZA887950B (en) 1987-04-29 1988-10-24 Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8701021A NL8701021A (en) 1987-04-29 1987-04-29 HUMANE T-PA (U-PA) SUBSTITUTION-MUTANT PROTEINS, CODING RECOMBINANT DNA, TRANSFECTED HOST CELLS, PREPARATION OF THE MUTANT PROTEINS, AND PHARMACEUTICAL PREPARATIONS.
ZA887950A ZA887950B (en) 1987-04-29 1988-10-24 Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA887950B true ZA887950B (en) 1989-07-26

Family

ID=26646238

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA887950A ZA887950B (en) 1987-04-29 1988-10-24 Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions

Country Status (1)

Country Link
ZA (1) ZA887950B (en)

Similar Documents

Publication Publication Date Title
IL74804A (en) Non-glycosylated polypeptide having human tnf activity,dna encoding it,its production and pharmaceutical compositions containing it
AU2535188A (en) Pharmaceutical compositions of recombinant beta-interferon and formulation processes
DE3277307D1 (en) Recombinant plasmid containing human interferon-beta gene
AU2928789A (en) Low ph pharmaceutical compositions of recombinant beta-interferon
IL79235A0 (en) Pharmaceutical compositions containing solubilized proteins and their preparation
AU3944885A (en) DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
NZ213563A (en) Anticoagulant proteins and pharmaceutical compositions
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
EP0210461A3 (en) Physiologically active polypeptide buf-3
NZ223551A (en) Human interleukin-3 and related proteins, production of these using genetic engineering methods and pharmaceutical compositions
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
AU6399786A (en) Polypeptides used in the diagnosis and therapy of AIDS
AU2724088A (en) Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
IL66920A0 (en) Dna's,recombinant dna's,hosts containing them,polypeptides and their production
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
AU4563185A (en) Novel pharmaceutical use of (NVA)``-cyclosporine
AU592791B2 (en) Recombinant DNA expression vectors and DNA compounds which encode isopenicillin N synthetase
NZ212291A (en) Peptide from human atrium cordis having diuretic action, dna coding therefor and pharmaceutical compositions thereof
IL76956A0 (en) Antibiotic polypeptide,its preparation and pharmaceutical compositions containing it
IL88934A0 (en) Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
ZA887950B (en) Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions
IL88173A0 (en) Human t-pa(u-pa)substitution-mutant proteins,recombinant dna coding therefor,transfected host cells,preparation of the mutant proteins,and pharmaceutical compositions
IL92316A0 (en) Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them
IL83594A0 (en) Human low affinity fce-receptor,its isolation,its recombinant preparation and pharmaceutical compositions containing it